Relief Therapeutics Holding SA (OTCMKTS:RLFTF – Get Free Report) fell 9% during mid-day trading on Monday . The company traded as low as $1.20 and last traded at $1.32. 1,011 shares traded hands during mid-day trading, a decline of 66% from the average session volume of 2,942 shares. The stock had previously closed at $1.45.
Relief Therapeutics Price Performance
The stock’s 50 day simple moving average is $1.68 and its 200-day simple moving average is $2.00.
About Relief Therapeutics
Relief Therapeutics Holding AG, a biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of metabolic, dermatological, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for radiotherapy induced nausea and vomiting, and chemotherapy induced nausea and vomiting, as well as postoperative induced nausea and vomiting.
Read More
- Five stocks we like better than Relief Therapeutics
- 5 Top Rated Dividend Stocks to Consider
- The Charles Schwab Company Can Hit New Highs
- High Flyers: 3 Natural Gas Stocks for March 2022
- Costco vs. Walmart: Revenue Comparison of Two Retail Giants
- How to Use the MarketBeat Dividend Calculator
- 3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
Receive News & Ratings for Relief Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relief Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
